| # | Title | Journal | Year | Citations |
|---|
| 1 | A variant associated with nicotine dependence, lung cancer and peripheral arterial disease | Nature | 2008 | 1,399 |
| 2 | Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer | European Urology | 2017 | 1,241 |
| 3 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines | European Urology | 2021 | 1,152 |
| 4 | EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines | European Urology | 2014 | 868 |
| 5 | The Epidemiology of Renal Cell Carcinoma | European Urology | 2011 | 817 |
| 6 | The present and future burden of urinary bladder cancer in the world | World Journal of Urology | 2009 | 772 |
| 7 | Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy | European Urology | 2009 | 584 |
| 8 | Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture | Nature Genetics | 2013 | 578 |
| 9 | A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci | Nature Genetics | 2010 | 493 |
| 10 | Renal Cell Carcinoma Guideline | European Urology | 2007 | 477 |
| 11 | Sequence variant on 8q24 confers susceptibility to urinary bladder cancer | Nature Genetics | 2008 | 377 |
| 12 | ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice | European Urology | 2009 | 332 |
| 13 | Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer | Nature Genetics | 2009 | 321 |
| 14 | The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer | European Urology | 2009 | 316 |
| 15 | Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer | European Urology | 2014 | 306 |
| 16 | MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study | Lancet Oncology, The | 2008 | 285 |
| 17 | Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort | European Urology | 2012 | 277 |
| 18 | A rare variant in MYH6 is associated with high risk of sick sinus syndrome | Nature Genetics | 2011 | 275 |
| 19 | Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review | European Urology | 2011 | 274 |
| 20 | Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis | European Urology | 2015 | 270 |
| 21 | A germline variant in the TP53 polyadenylation signal confers cancer susceptibility | Nature Genetics | 2011 | 251 |
| 22 | Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density | Nature Genetics | 2009 | 248 |
| 23 | A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group | Journal of Urology | 2011 | 247 |
| 24 | Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer | European Urology | 2011 | 225 |
| 25 | Economic Burden of Bladder Cancer Across the European Union | European Urology | 2016 | 223 |
| 26 | Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 | Nature Genetics | 2011 | 220 |
| 27 | Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel | European Urology | 2016 | 215 |
| 28 | Three-Tesla Magnetic Resonance–Guided Prostate Biopsy in Men With Increased Prostate-Specific Antigen and Repeated, Negative, Random, Systematic, Transrectal Ultrasound Biopsies: Detection of Clinically Significant Prostate Cancers | European Urology | 2012 | 204 |
| 29 | A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study | European Urology | 2016 | 201 |
| 30 | Hexyl Aminolevulinate–Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non–Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature | European Urology | 2013 | 193 |
| 31 | Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer | Clinical Cancer Research | 2015 | 193 |
| 32 | 180-W XPS GreenLight Laser Vaporisation Versus Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 6-Month Safety and Efficacy Results of a European Multicentre Randomised Trial—The GOLIATH Study | European Urology | 2014 | 189 |
| 33 | Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy | European Urology | 2010 | 183 |
| 34 | Comparison of laparoscopic and mini incision open donor nephrectomy: single blind, randomised controlled clinical trial | BMJ: British Medical Journal | 2006 | 181 |
| 35 | The Predictive Value of Endorectal 3 Tesla Multiparametric Magnetic Resonance Imaging for Extraprostatic Extension in Patients with Low, Intermediate and High Risk Prostate Cancer | Journal of Urology | 2013 | 177 |
| 36 | The Time-Resolved Fluorescence-Based PCA3 Test on Urinary Sediments after Digital Rectal Examination; a Dutch Multicenter Validation of the Diagnostic Performance | Clinical Cancer Research | 2007 | 176 |
| 37 | A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer | Nature Genetics | 2010 | 169 |
| 38 | IMRT boost dose planning on dominant intraprostatic lesions: Gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI | International Journal of Radiation Oncology Biology Physics | 2006 | 168 |
| 39 | Association of Variants at UMOD with Chronic Kidney Disease and Kidney Stones—Role of Age and Comorbid Diseases | PLoS Genetics | 2010 | 166 |
| 40 | The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review | European Urology | 2011 | 166 |
| 41 | The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer | European Urology | 2010 | 160 |
| 42 | The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma | European Urology | 2022 | 158 |
| 43 | EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) | European Urology | 2019 | 151 |
| 44 | European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma | British Journal of Surgery | 2017 | 148 |
| 45 | Predictive value of PCA3 in urinary sediments in determining clinico‐pathological characteristics of prostate cancer | Prostate | 2010 | 144 |
| 46 | Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort | BMJ: British Medical Journal | 2010 | 143 |
| 47 | Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial | Lancet Oncology, The | 2013 | 142 |
| 48 | Urinary Markers in Bladder Cancer | European Urology | 2008 | 140 |
| 49 | Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels | Science Translational Medicine | 2010 | 140 |
| 50 | Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment | Journal of the National Cancer Institute | 2017 | 139 |
